CorMedix (CRMD) PT Lowered to $16 at Truist Securities
Get Alerts CRMD Hot Sheet
Price: $7.54 -7.37%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Truist Securities analyst Joon Lee lowered the price target on CorMedix (NASDAQ: CRMD) to $16.00 (from $27.00) while maintaining a Buy rating.
You May Also Be Interested In
- CorMedix (CRMD) PT Raised to $14 at RBC Capital
- H.C. Wainwright Reiterates Buy Rating on CorMedix (CRMD)
- Today's Stocks in the News
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share